Skip to content

Clinical trials

Phase 2 Hereditary Sensory and Autonomic Neuropathies trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hereditary Sensory and Autonomic Neuropathies Phase: Phase 2 Country / region: France Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20183
20191
20201
20212
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
EMD Serono Research & Development Institute, Inc.2
Actuate Therapeutics Inc.1
AllRock Bio, Inc.1
AstraZeneca1
Centre Hospitalier Universitaire Dijon1
Incyte Corporation1
Novartis Pharmaceuticals1
Pfizer1
Revolution Medicines, Inc.1
UNICANCER1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hereditary Sensory and Autonomic Neuropathies11
Breast Neoplasms3
Lung Neoplasms2
Neoplasms2
Anemia, Hemolytic, Autoimmune1
Bone Neoplasms1
Bronchial Neoplasms1
Carcinoma1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.